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Abstract
Background: Leishmaniasis is an emerging infectious disease. Due to human migration and tourism, visceral
leishmaniasis may become more common in non-endemic areas. In the Mediterranean basin, visceral leishmaniasis
typically occurs in rural regions.
Case presentation: We present an unusual urban case of acute liver failure due to visceral leishmaniasis, following
a prolonged fever of unknown origin. After obtaining negative results from the bone marrow aspirate, we
performed a liver biopsy that elucidated the diagnosis. The liver involvement in visceral leishmaniasis may appear
as chronic granulomatous hepatitis. However diffuse hepatitis process, a necro-inflammatory pattern, without
forming granulomas were observed in the liver biopsy specimens in this case. Intracytoplasmic Leishmania
amastigotes were observed in the liver biopsy specimens and a polymerase chain reaction confirmed the diagnosis.
Only five pathological confirmed cases of acute hepatitis due to visceral leishmaniasis have been described so far,
just two in adults and both from Barcelona. A revision of the literature is performed.
Conclusions: Acute hepatitis is an uncommon debut of visceral leishmaniasis in immunocompetent patients.
Furthermore there are only few cases in the literature that describe the histopathological changes that we found in
this patient. In conclusion, in case of acute hepatitis leading to liver failure, leishmaniasis should be considered a
differential diagnosis (even in non-endemic countries and without clear epidemiological exposure) and liver biopsy
can elucidate the diagnosis.
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Background
Leishmaniasis is an emerging infectious disease, caused
by protozoa that live inside macrophages in mammals.
Sandflies become infected after feeding on the reservoir
animal (rodents, dogs, and other small mammals) or in-
fected humans and can then transmit the parasite to
other humans [1].
Clinical manifestations are dependent both on the in-
fecting species of Leishmania and the immune response
of the host. Many cases are asymptomatic, reflecting the
ability of the host immune system to control the parasite.
There are two main clinical forms: visceral leishmaniasis
and cutaneous leishmaniasis. Cutaneous leishmaniasis
presents as single or multiple papular, nodular or ulcerous
skin lesions. Visceral leishmaniasis is the most serious
clinical form of this disease. Persistent fever, splenomegaly
and pancytopenia characterize visceral leishmaniasis [1].
An infrequent form of leishmaniasis is localized leishman-
ial lymphadenopathy without fever or skin lesions. After
the largest outbreak of leishmaniasis in Europe a series of
cases of localized leishmanial lymphadenopathy was pub-
lished. The presentation as fulminant hepatitis is even
more uncommon [2].
The global incidence of visceral leishmaniasis de-
creased substantially in the past decade: from between
200,000 and 400,000 new cases in 2012, to between 50,
000 and 90,000 new cases in 2017 [1]. Among tropical
diseases, leishmaniasis ranks second in mortality and
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seventh in loss of disability-adjusted life years [3].
Outbreaks of human leishmaniasis are unusual in Spain,
despite being considered an endemic disease. Here we
describe a case of acute hepatitis with liver failure as vis-
ceral leishmaniasis presentation in an immunocompe-
tent adult from an urban area in Barcelona.
Case presentation
A 55-year-old man resident in Barcelona was evalu-
ated for a 2-week history of unexplained fever despite
antipyretic treatment. Medical record was positive
only for hypertension controlled with enalapril. He
was born in Barcelona and he always lived there. 2
years ago he had traveled to China and Israel, and 10
years ago to several countries of South America, with
no other relevant epidemiological risk. The patient
denied alcohol intake previous to admission At ad-
mission he was 39.1 °C, the heart rate was 89 bpm,
and the blood pressure was 123/66 mmHg. Physical
examination was unremarkable. Initial blood test re-
vealed increased C-reactive protein levels to 10.55 mg/
dL, elevated aspartate aminotransferase (88 U/L), ala-
nine aminotransferase (76 U/L), alkaline phosphatase
(202 U/L) and gamma glutamyl transferase (269 U/L).
Bilirubin and prothrombin time were within normal
range. The hemoglobin was 12.7 g/dl and laboratory test
showed leukopenia (2.83 × 109/L) and thrombopenia
(115 × 109). Blood and urine cultures were taken on admis-
sion. Chest radiography was normal. Due to fever and ana-
lytical results it was decided to perform an abdominal
ultrasonography revealing a hypoechoic lesion suggestive of
a subcapsular splenic infarction. Infective endocarditis was
suspected, starting an antibiotic combination of intravenous
ampicillin 2 g/ 4 hs, cloxacillin 2 g/4 hs and ceftriax-
one 2 g/12 hs. Transthoracic echocardiography was
unremarkable and blood cultures were negative, dis-
continuing ampicillin and cloxacillin.
The patient continued having febrile peaks over 2
weeks, treated mainly by physical measures to avoid
hepatotoxic drugs. A computed tomography revealed 15
cm-splenomegaly and several splenic infarctions, with no
other abnormalities. Repeated blood analysis showed
worsening of liver tests (AST 1649U/L, ALT 911 U/L,
gamma GT 447 U/L, total bilirubin 4.20 mg/dl, ammo-
nium 82 μmol/L, albumin 2.4 mg/dl, prothrombin time
of 40%), pancytopenia (hemoglobin 8 g/L, platelets
48 × 109), high levels of triglycerides 222 mg/dl, ele-
vated ferritin 12.886 ng/mL, lactic dehydrogenase 915
U/L, total proteins 55 g/l, normal kidney function test
and normal blood smear.
Microbiology investigations (including serologies
and molecular biology) were negative for tuberculosis,
Coxiella, Brucella, Human immunodeficiency virus,
viral hepatitis (A to E), Cytomegalovirus, Epstein-Barr
virus and parvovirus B19. IgG for Leishmania was
positive, with a title of 1:200 by IIFT technique and
IgM was negative. He had low titers of antinuclear and
anti-smooth muscle antibodies (1:80). Given these findings
it was decided to perform a bone marrow aspiration and a
18F-fluorodeoxyglucose-positron emission tomography in
combination with computed tomography scanning (FDG-
PET/TC). There were no signs of haematologic malig-
nancy in the bone marrow and there were no hemophago-
cytosis. Aspirated material inoculated into parasitic
growth media and a Giemsa-stained smear was made,
both were negative. FDG-PET/TC revealed a diffuse high
uptake in the spleen, liver, and bone marrow but without
involvement of lymph nodes or other organs (Fig. 1).
Given the worsening of liver tests, a diagnostic liver
biopsy was performed and histopathology showed an
acute hepatitis with confluent necrosis and mixed in-
flammatory infiltrates with abundant plasmatic and
histiocytic cells. Isolated macrophages with intracyto-
plasmic Leishmania amastigotes were observed (Fig. 2).
Polymerase chain reaction in tissue was positive for
Leishmania infantum. The patient started treatment
with liposomal amphotericin B 3 mg/kg/day for 5 days
and two additional single weekly doses, at day 14th
and 21st, showing slow but continuous analytical and
clinical involvement. He was completely recovered 1
month later.
Discussion and conclusion
In 2017 the global incidence of visceral leishmaniasis
was 50.000–90.000 new cases. Persistent irregular
fever, splenomegaly, pancytopenia, weight loss and
hypergammaglobulinemia characterize visceral leish-
maniasis. Hepatomegaly is common in patients with
Fig. 1 FDG-PET/TC. FDG-PET scans shows diffuse high uptake in the
spleen (SUV máx: 13.26), liver, and bone marrow
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visceral leishmaniasis and late in the course of dis-
ease, hepatic dysfunction, jaundice, and ascites can
occur [1]. However rapid acute progressive hepatitis
as a presenting feature is rare.
Definitive diagnosis of visceral leishmaniasis re-
quires demonstration of the parasite by either histo-
pathology or culture of material obtained by needle
aspiration or biopsy from affected organs (usually
bone marrow or spleen). In our case we performed a
bone marrow aspiration and aspirated material inoc-
ulated into parasitic growth media and a Giemsa-
stained smear was made, but both were negative.
Unfortunately, PCR was not available in our institu-
tion, what may have provided an earlier diagnosis.
Death occurs in more than 90% of patients without
specific anti-leishmanial treatment. Therefore, a cor-
rect diagnosis of visceral leishmaniasis is essential.
After obtaining negative results from the bone mar-
row aspirate, we performed a liver biopsy. Intracyto-
plasmic Leishmania amastigotes were observed in
the liver biopsy specimens and a polymerase chain
reaction requested to the national reference center
confirmed the diagnosis.
Only few cases of acute hepatitis as a presenting form
of visceral leishmaniasis are reported in the literature
and many of them do not have a histopathological
study of the liver. Just 4 previous cases with a liver bi-
opsy were reported so far. The cases are summarized in
the table (Table 1) [4–7]. Three of the published cases
are in children, in Indian [7]. Since visceral leishmania-
sis preferentially affects children or immunosuppressed
adults, interestingly, in this adult patient, no evidenced
of immunodeficiency was detected.
The liver involvement in visceral leishmaniasis may
appear as chronic granulomatous hepatitis [8]. El
Hag et al has reported histopathology changes in the
liver in visceral leishmaniasis [9]. All cases had
inflammation, Kupffer cell hyperplasia, intracellular
amastigotes, focal and piecemeal necrosis. The histo-
pathological findings of the case reported here
mimics that published last year by Bassegoda et al.
(also from Barcelona) and evidenced diffuse hepatitis
process, a necro-inflammatory pattern, accompanying
inflammatory infiltrate was mixed, with abundant
plasmatic and histiocytic cells, without forming
granulomas [6]. Very small, oval structures in the
cytoplasm of some macrophages were suggestive of
Leishmania amastigotes. The disease is rare in Spain
and no common exposure or link could be traced
between the two cases. Although a clear epidemio-
logical exposure for our case was not identified,
Leishmania infantum is endemic in the Mediterra-
nean basin and therefore, exposure could have oc-
curred even in Spain [1]. Interestingly the two only
adult cases were from Barcelona and both had nega-
tive Leishmania detection in bone marrow samples.
Acute hepatitis is an uncommon debut of visceral
leishmaniasis in immunocompetent patients. Fur-
thermore there are only few cases in the literature
that describe the histopathological changes that we
found in this patient. In conclusion, in case of
acute hepatitis leading to liver failure, leishmaniasis
should be considered a differential diagnosis (even
in non-endemic countries and without clear epi-
demiological exposure) and liver biopsy can eluci-
date the diagnosis.
Fig. 2 Histopathological study of the liver. a On the left side, liver biopsy showed an acute hepatitis with centrilobular necrosis, mixed
inflammation and abundant Kupffer cells (Hematoxilin & Eosin, 10X). b Scattered small oval structures with rod-shaped kinetoplast (black arrow)
were observed in the cytoplasm of some hepatocytes and Kupffer cells (Hematoxilin & Eosin, 40X)
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